SAN DIEGO, CA--(Marketwire - Feb 23, 2012) - Cytori Therapeutics (NASDAQ: [ CYTX ]) will provide a live webcast of its fourth quarter and year end financial results and business update on Thursday, March 8, 2012 at 5:00 PM Eastern Time.

Prior to the webcast at approximately 4:05 PM Eastern Time on March 8, Cytori will issue its year end earnings release and post a quarterly shareholder letter to its Investor Relations homepage, which will review Cytori's fourth quarter and full year performance.

The webcast will be available both live and by replay two hours after the call on the Company's website, under "Webcasts" on the Investor Relations page ([ http://ir.cytoritx.com ]).

About Cytori

Cytori is a leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets and available in the United States only for use as an investigational device under Cytori's FDA approved IDE. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft® products are available in North America and Europe for fat grafting procedures. [ www.cytori.com ]